Search Results - Peter Shrader

Refine Results
  1. 1
    Effectiveness of a Computerized Insulin Order Template in General Medical Inpatients With Type 2 Diabetes

    Effectiveness of a Computerized Insulin Order Template in General Medical Inpatients With Type 2 Diabetes by Deborah J. Wexler, Peter Shrader, Sean M. Burns, Enrico Cagliero

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records

    Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records by Marie‐France Hivert, Richard W. Grant, Peter Shrader, James B. Meigs

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Diabetes Risk Perception and Intention to Adopt Healthy Lifest yles Among Primary Care Patients

    Diabetes Risk Perception and Intention to Adopt Healthy Lifest yles Among Primary Care Patients by Marie‐France Hivert, Ana Sofia Warner, Peter Shrader, Richard W. Grant, James B. Meigs

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Circulating IL-18 and the risk of type 2 diabetes in women

    Circulating IL-18 and the risk of type 2 diabetes in women by Marie‐France Hivert, Qi Sun, Peter Shrader, Christos S. Mantzoros, James B. Meigs, Frank B. Hu

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Pretreatment, Psychological, and Behavioral Predictors of Weight Outcomes Among Lifestyle Intervention Participants in the Diabetes Prevention Program (DPP)

    Pretreatment, Psychological, and Behavioral Predictors of Weight Outcomes Among Lifestyle Intervention Participants in the Diabetes Prevention Program (DPP) by Linda M. Delahanty, Mark Peyrot, Peter Shrader, Donald A. Williamson, James B. Meigs, David M. Nathan

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])

    Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atri... by Tharian S. Cherian, Peter Shrader, Gregg C. Fonarow, Larry A. Allen, Jonathan P. Piccini, Eric D. Peterson, Laine Thomas, Peter R. Kowey, Bernard J. Gersh, Kenneth W. Mahaffey

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms

    Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms by José M. de Miguel‐Yanes, Peter Shrader, Michael Pencina, Caroline S. Fox, Alisa K. Manning, Richard W. Grant, Josée Dupuis, José C. Florez, Ralph B. D’Agostino, L. Adrienne Cupples, James B. Meigs

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes

    Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes by James B. Meigs, Peter Shrader, Lisa Sullivan, Jarred B. McAteer, Caroline S. Fox, Josée Dupuis, Alisa K. Manning, José C. Florez, Peter W.F. Wilson, Ralph B. D’Agostino, L. Adrienne Cupples

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)

    Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatmen... by Kevin L. Thomas, Larry R. Jackson, Peter Shrader, Jack Ansell, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Daniel E. Singer, Laine Thomas, Jonathan P. Piccini, Eric D. Peterson

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Predictors of Disease Progression in Pediatric Dilated Cardiomyopathy

    Predictors of Disease Progression in Pediatric Dilated Cardiomyopathy by Kimberly Molina, Peter Shrader, Steven D. Colan, Seema Mital, Renée Margossian, Lynn A. Sleeper, Girish Shirali, Piers Barker, Charles E. Canter, Karen Altmann, Elizabeth Radojewski, Elif Seda Selamet Tierney, Jack Rychik, Lloyd Y. Tani

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes

    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes by Justin B. Echouffo‐Tcheugui, Peter Shrader, Laine Thomas, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Daniel E. Singer, Elaine M. Hylek, Alan S. Go, Eric D. Peterson, Jonathan P. Piccini, Gregg C. Fonarow

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation

    Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation by Ambarish Pandey, Bernard J. Gersh, Darren K. McGuire, Peter Shrader, Laine Thomas, Peter R. Kowey, Kenneth W. Mahaffey, Elaine M. Hylek, Shining Sun, Paul Burton, Jonathan P. Piccini, Eric D. Peterson, Gregg C. Fonarow

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes

    Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes by Benjamin A. Steinberg, Peter Shrader, Laine Thomas, Jack Ansell, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli, James A. Reiffel, Daniel E. Singer, Eric D. Peterson, Jonathan P. Piccini

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Factors associated with non–vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

    Factors associated with non–vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Be... by Benjamin A. Steinberg, Peter Shrader, Laine Thomas, Jack Ansell, Gregg C. Fonarow, Bernard J. Gersh, Elaine M. Hylek, Peter R. Kowey, Kenneth W. Mahaffey, Emily C. O’Brien, Daniel E. Singer, Eric D. Peterson, Jonathan P. Piccini

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Management and outcomes of patients with atrial fibrillation and <i>a history of</i> cancer: the ORBIT-AF registry

    Management and outcomes of patients with atrial fibrillation and <i>a history of</i> cancer: the ORBIT-AF registry by Chiara Melloni, Peter Shrader, Joseph R. Carver, Jonathan P. Piccini, Laine Thomas, Gregg C. Fonarow, Jack Ansell, Bernard J. Gersh, Alan S. Go, Elaine M. Hylek, Irving M. Herling, Kenneth W. Mahaffey, Anthony F. Yu, Eric D. Peterson, Peter R. Kowey

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation

    Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation by James V. Freeman, Peter Shrader, Karen S. Pieper, Larry A. Allen, Paul S. Chan, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli, James A. Reiffel, Daniel E. Singer, Alan S. Go, Elaine M. Hylek, Benjamin A. Steinberg, Eric D. Peterson, Jonathan P. Piccini

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Survival Data and Predictors of Functional Outcome an Average of 15 Years after the Fontan Procedure: The Pediatric Heart Network Fontan Cohort

    Survival Data and Predictors of Functional Outcome an Average of 15 Years after the Fontan Procedure: The Pediatric Heart Network Fontan Cohort by Andrew M. Atz, Victor Zak, Lynn Mahony, Karen Uzark, Peter Shrader, Dianne Gallagher, Stephen M. Paridon, Richard V. Williams, Roger E. Breitbart, Steven D. Colan, Jonathan R. Kaltman, Renée Margossian, Sara K. Pasquali, Kerstin Allen, Wyman W. Lai, Rosalind Korsin, Bradley S. Marino, Nicole Mirarchi, Brian W. McCrindle

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Cause, timing, and location of death in the Single Ventricle Reconstruction trial

    Cause, timing, and location of death in the Single Ventricle Reconstruction trial by Richard G. Ohye, Julie V. Schonbeck, Pirooz Eghtesady, Peter C. Laussen, Christian Pizarro, Peter Shrader, Deborah U. Frank, Eric M. Graham, Kevin D. Hill, Jeffrey P. Jacobs, Kirk R. Kanter, Joel A. Kirsh, Linda M. Lambert, Alan B. Lewis, Chitra Ravishankar, James S. Tweddell, Ismée A. Williams, Gail D. Pearson

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes

    Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes by Taku Inohara, Peter Shrader, Karen S. Pieper, Rosalia Blanco, Laine Thomas, Daniel E. Singer, James V. Freeman, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Michael D. Ezekowitz, Peter R. Kowey, James A. Reiffel, Gerald V. Naccarelli, Paul S. Chan, Benjamin A. Steinberg, Eric D. Peterson, Jonathan P. Piccini

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)

    Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation... by Benjamin A. Steinberg, Peter Shrader, Karen S. Pieper, Laine Thomas, Larry A. Allen, Jack Ansell, Paul S. Chan, Michael D. Ezekowitz, Gregg C. Fonarow, James V. Freeman, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli, James A. Reiffel, Daniel E. Singer, Eric D. Peterson, Jonathan P. Piccini

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: